- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Acute Myeloid Leukemia
Medical specialists from France tagged as investigators in clinical trials studying Acute Myeloid Leukemia
Total 264 results
-
Stéphanie MORISSONSeen in:
- Saint-Priest-en-Jarez, Institut de Cancerologie de La Loire
Trials:- NCT03800095 (Sub-Investigator)
-
Stéphanie Nguyen, MDSeen in:
- Paris, Hôpital de la Pitié-Salpétrière
Trials:- NCT03439371 (Principal Investigator)
Conditions: -
Sylvain ChantepieSeen in:
- Caen, CHU Caen
- Caen, CHU de Caen
- Caen, CHU de Caen Normandie
- Caen, Institut d'hématologie de Basse Normandie (IHBN)
Trials:- NCT05260528 (Principal Investigator)
- NCT04905407 (Principal Investigator)
- NCT02473146 (Principal Investigator)
- NCT03450512 (Principal Investigator)
Conditions: -
Sylvain Garciaz, Dr.Seen in:
- Marseille, Institute Paoli-Calmettes
Trials:- NCT04086264 (Principal Investigator)
Conditions: -
Sylvain Thepot, MDSeen in:
- Angers, CHU Angers
- Angers, CHU d'Angers
Trials:- NCT04905407 (Principal Investigator)
- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
T. CluzeauSeen in:
- Nice, FR-Nice-LARCHET
Trials:- NCT04027309 (Principal Investigator)
-
Thierry ODENT, MD-PhDSeen in:
- Tours, Service de chirurgie orthopédique pédiatrique -CHRU TOURS
Trials:- NCT05792007 (Principal Investigator)
-
Thomas BACHELOTSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
- NCT02029001 (Sub-Investigator)
-
Thomas CluzeauSeen in:
- Nice, Archet 1 Hospital
- Nice, CHU de Nice
- Nice, CHU de Nice - Hopital L'Archet
- Nice, CHU de Nice - Hôpital Archet 1
- Nice, CHU de Nice - Hôpital de l'Archet
- Nice, Hôpital Archet 1/Service d'Hématologie Clinique
- Nice, Hôpital l'Archet- CHU de Nice
Trials:- NCT04797780 (Principal Investigator)
- NCT04905407 (Principal Investigator)
- NCT03643042 (Principal Investigator)
- NCT05260528 (Principal Investigator)
- NCT01210274 (Principal Investigator)
- NCT03829072 (Principal Investigator)
- NCT03503409 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT04827719 (Principal Investigator)
- NCT05181735 (Principal Investigator)
- NCT06030089 (Principal Investigator)
-
Thorsten BraunSeen in:
- Bobigny, FR-Bobigny-AVICENNE
- Bobigny, Hôpital Avicenne
- Bobigny, Hôpital Avicenne APHP
- Bobigny, Hôpital Avicenne Hématologie Clinique
Trials:- NCT04797780 (Principal Investigator)
- NCT04027309 (Principal Investigator)
- NCT05260528 (Principal Investigator)
- NCT04905407 (Principal Investigator)
-
Valérie Coiteux, MDSeen in:
- Lille, CHRU de Lille
Trials:- NCT03439371 (Sub-Investigator)
Conditions: -
Victoria Cacheux, MDSeen in:
- Clermont-Ferrand, CHU Estaing
- Clermont-Ferrand, Chu Cth Estaing Clermont Ferrand
Trials:- NCT03439371 (Sub-Investigator)
- NCT04384341 (Sub-Investigator)
Conditions: -
Violette MESDAGSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Virginie GuastellaSeen in:
- Clermont-Ferrand, CHU Clermont-Ferrand
- Clermont-Ferrand, CHU de Clermont-Ferrand
Trials:- NCT03800095 (Principal Investigator)
- NCT05761587 (Principal Investigator)
-
Waisse WAISSISeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Xavier THOMAS, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud, Hematology department
Trials:- NCT03796533 (Sub-Investigator)
Conditions: -
Y. DesbrossesSeen in:
- Besançon, FR-Besançon Cedex-JEANMINJOZ
Trials:- NCT04027309 (Principal Investigator)
-
Yann GUILLERMINSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04052126 (Sub-Investigator)
- NCT04671693 (Sub-Investigator)
Conditions:- Quality of Life;
- Lymphoma, Non-Hodgkin;
- Leukemia, Myeloid, Acute;
- Fatigue;
- Exercise;
- Aged;
- Aged, 80 and Over;
- Acute Myeloid Leukemia;
- Hodgkin Disease;
- Osteosarcoma;
- Non Hodgkin Lymphoma;
- Late Effects;
- Ewing's Sarcoma;
- Testicular Germ Cell Tumor Mixed;
- Non-Metastatic Breast Carcinoma;
- Soft Tissue Sarcoma, Adult, Stage IIC
-
Yohan DesbrossesSeen in:
- Besançon, CHRU Jean Minjoz
Trials:- NCT05260528 (Principal Investigator)
Conditions:
Clinical Trials on Acute Myeloid Leukemia
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingSecondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States